CHF82.55
0.79% today
SIX Swiss Exchange, Feb 05, 04:16 pm CET
ISIN
CH0360674466
Symbol
GALE

Galenica Stock price

CHF81.90
+6.20 8.19% 1M
+7.35 9.86% 6M
+7.55 10.15% YTD
+6.20 8.19% 1Y
+17.40 26.98% 3Y
+15.10 22.60% 5Y
+38.90 90.47% 10Y
SIX Swiss Exchange, Closing price Tue, Feb 04 2025
+0.25 0.31%
ISIN
CH0360674466
Symbol
GALE
Sector

Key metrics

Market capitalization CHF4.08b
Enterprise Value CHF4.92b
P/E (TTM) P/E ratio 23.04
EV/FCF (TTM) EV/FCF 22.53
EV/Sales (TTM) EV/Sales 1.30
P/S ratio (TTM) P/S ratio 1.08
P/B ratio (TTM) P/B ratio 2.90
Dividend yield 2.69%
Last dividend (FY23) CHF2.20
Revenue growth (TTM) Revenue growth -2.84%
Revenue (TTM) Revenue CHF3.79b
EBIT (operating result TTM) EBIT CHF203.15m
Free Cash Flow (TTM) Free Cash Flow CHF218.17m
EPS (TTM) EPS CHF3.55
P/E forward 23.94
P/S forward 1.04
EV/Sales forward 1.25
Show more

Is Galenica a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Galenica Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Galenica forecast:

2x Buy
33%
4x Hold
67%

Analyst Opinions

6 Analysts have issued a Galenica forecast:

Buy
33%
Hold
67%

Financial data from Galenica

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
3,795 3,795
3% 3%
100%
- Direct Costs 3,414 3,414
3% 3%
90%
381 381
3% 3%
10%
- Selling and Administrative Expenses 74 74
8% 8%
2%
- Research and Development Expense - -
-
-
308 308
6% 6%
8%
- Depreciation and Amortization 104 104
2% 2%
3%
EBIT (Operating Income) EBIT 203 203
8% 8%
5%
Net Profit 177 177
34% 34%
5%

In millions CHF.

Don't miss a Thing! We will send you all news about Galenica directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galenica Stock News

EQS
13 days ago
Willkommen im Galenica-Netzwerk! Die über 8’000 Mitarbeitenden von Galenica setzen sich täglich ein für die Gesundheit und das Wohlbefinden der Menschen in der Schweiz. Mit den Apotheken, der Pharmalogistik, unseren Produkten und Dienstleistungen sowie dem Bereich Home Care ist Galenica breit auf...
EQS
13 days ago
Nach einer soliden Umsatzsteigerung im ersten Halbjahr 2024 von 2.6% ist Galenica im zweiten Halbjahr 2024 mit +6.7% wieder deutlich stärker gewachsen. Marktanteilsgewinne im Grosshandelsgeschäft mit Ärzten und Apotheken trugen massgeblich zur Umsatzsteigerung bei. Hauptwachstumstreiber im Apothe...
AD HOC NEWS
14 days ago
Galenica AG / CH0360674466
More Galenica News

Company Profile

Galenica AG engages as a health care provider in Switzerland. It operates through the following segments: Health & Beauty and Services. The Health and Beauty segment comprises the two business sectors Retail; and Products and Brands. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company was founded on 1927 and is headquartered in Bern, Switzerland.

Head office Switzerland
CEO Marc Werner
Employees 5,907
Founded 1927
Website www.galenica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today